Learn More
Medchemexpress LLC 1,4-Oxazepin-5(2H)-one, 4-[3-[[2-[[2-ethyl-4-(4-methyl-1-piperazinyl)phenyl)amino]-5-... | 2543673-19-2 | 99.7% | 535.60 | 1 G

Supplier: Medchemexpress LLC HY1606991G
DCC-3116 is an orally active ULK1/2 inhibitor. It inhibits autophagy in lung cancer cells by targeting KRASG12C signaling, which in turn reduces the proliferation of lung cancer cells and exerts anti-cancer effects.
- Orally active ULK1/2 inhibitor
- Inhibits autophagy in lung cancer cells
- Targets KRASG12C signaling
- Reduces proliferation of lung cancer cells
- Exerts anti-cancer effects
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.